BioEclipse Therapeutics
7 employees
Biotech/Pharma
Seed · $13.7M
Open positions (1)
Company details
Team Size7
IndustryBiotech/Pharma
Funding
Total raised
$13.7M
Last stage
Seed
Investors
Plum Alley Investments
Total raised
$13.7M
Last stage
Seed
Investors
Pamela Contag
Biopharmaceutical entrepreneur and researcher with 25+ years of experience. Co-founded BioEclipse Therapeutics (initially named ConcentRX), raising seed funding and licensing key patents from Stanford University. Named by Goldman Sachs as one of the 100 Most Intriguing Entrepreneurs of 2018.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.